Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

eptinezumab

- PMLiVE

Former Nycomed CEO Hakan Bjorklund to chair Lundbeck

Mats Pettersson to step down in March

Pharma deals during January 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Lundbeck looks to new products as Lexapro slumps

Denmark-based pharma company reports flat sales during fourth quarter of 2012

Icon buys Cross Country Healthcare’s clinical trials division

Will boost functional service provision and pharmacovigilance efforts

- PMLiVE

Lundbeck launches Chorea Matters online resource

Includes recognising chorea education programme

- PMLiVE

Pharma’s reputation declining say patient groups

Pricing policies and a lack of transparency lead list of grievances

- PMLiVE

Hikma expands in Egypt with EPCI acquisition

Deal in fast-growing North African market is worth about $22m

Roche - Basel

Roche ends pursuit of gene sequencing company Illumina

Says chairman Franz Humer following failed $6.8bn bid

Pharma deals during December 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Lundbeck slumps as it cuts sales, profit guidance

Comes despite three new products due to hit market

- PMLiVE

EMA recommends approval for alcohol dependency drug

Lundbeck’s Selincro to be used in conjunction with psychosocial support

Pharma deals during November 2012

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links